Get the latest news and updates on FINTECH.TV Skye Bioscience’s Developing Treatment for Glaucoma Daily Download February 22, 2023 Share FacebookTwitterPinterestWhatsApp Join us for a discussion about Skye Bioscience’s developing treatment for glaucoma using a synthetic cannabinoid. Our guest, CEO of Skye Bioscience, Punit Dhillon, breaks down this new innovation further with our guest Alicia Nieves. Related posts: Speculation Growing Over Uses for ChatGPT AI Sweater Aiming to Make Venture Capital More Accessible SEC Cracks Down on Kraken Exploring The Future Of The Metaverse Advertisement Latest articles Market Volatility Tests Investors as Earnings, Metals, and Crypto Swing Market Movers: The Opening Bell February 2, 2026 Gold and Silver Retreat After Record Surge as Markets Reassess Policy Market Movers: The Opening Bell February 2, 2026 India’s Rising Influence Tests U.S. Foreign Policy Strategy Market Movers: The Opening Bell February 2, 2026 Digital Asset Allocators Emphasize Risk Management as Institutions Move In Market Movers: The Opening Bell February 2, 2026 Related articles Market Volatility Tests Investors as Earnings, Metals, and Crypto Swing Market Movers: The Opening Bell February 2, 2026 Gold and Silver Retreat After Record Surge as Markets Reassess Policy Market Movers: The Opening Bell February 2, 2026 India’s Rising Influence Tests U.S. Foreign Policy Strategy Market Movers: The Opening Bell February 2, 2026